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 Abstract 
 Objective: Worldwide increasing childhood obesity is due to interactions between environ-
mental and genetic factors, linked together by epigenetic mechanisms such as DNA methyla-
tion.  Methods:  82 obese children (>95th BMI percentile , age: 3–18 years) were included. An-
thropometric data, metabolic parameters, 25-OH vitamin D (25OHD), and pubertal status 
were recorded, 24-hour blood pressure monitoring was performed. BMI standard deviation 
score (SDS) was calculated. Using candidate gene approach, obesity- (insulin-like growth fac-
tor 2 ( IGF2 ), proopiomelanocortin ( POMC )) and vitamin D metabolism-related genes (1-alfa-
hydroxylase ( CYP27B1 ),  VDR )  regulated by DNA methylation were selected. After isolating 
DNA from peripheral blood, bisulfite conversion, bisulfite specific polymerase chain reaction 
(BS-PCR), and pyrosequencing were carried out.  Results:  No significant correlation between 
25-OHD and metabolic parameters and DNA methylation status, but a tendency of positive 
correlation between VDR methylation status and 25-OHD (r = 0.2053,p = 0.066) were ob-
served. Significant positive correlations between BMI SDS and  CYP27B1 hypermethylation 
(r = 0.2371,p = 0.0342) and a significant negative correlation between  IGF2  hypomethylation 
and BMI SDS (r = –0.305,p = 0.0059) were found.  Conclusions  Rate of obesity shows correla-
tion with DNA methylation. Hypomethylation of  IGF2 and hypermethylation of  CYP27B1 
genes might positively influence the rate of BMI observed in obese children. 
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 Introduction 
 The prevalence of obesity has been increasing dramatically over the past years not only 
worldwide but in European countries as well. This condition tends to appear at younger ages, 
which indicates that the risk factors, comorbidities, and consequences of obesity start getting 
in action very early on in life  [1] . The increase of body weight is also correlated with an 
increased risk of type 2 diabetes, cardiovascular diseases, cancer, and mortality  [2] . The cause 
of obesity is complex and includes endogenous and exogenous factors. Researchers suggest 
that the main exogenous factor of the worldwide increasing weight gain is the ‘obesogenic 
environment’, which includes unfavorable changes in lifestyle and environment. At the level 
of individuals obesity is present when energy intake exceeds energy expenditure. But also 
endogenous factors can play a role in developing obesity. According to genomewide associ-
ation studies (GWAS) more than 40 genetic variants have been associated with obesity and 
shifting in fat distribution, while gene-environment interaction is also proposed to be an 
important factor for causing obesity. 
 According to recent studies, obesity results mainly from interactions between environ-
mental and genetic factors, which are linked together by epigenetic mechanisms  [3, 4] . The 
so-called epigenetic marking or ‘imprinting’ affects gene function and expression without 
modifying the DNA sequence. Epigenetic marks are tissue-specific and include DNA methyl-
ation, histone modification and micro RNA pathways, and influence cell function as well as 
molecular and metabolic processes  [3] . Some nutritional components are able to influence 
the expression of some of the key genes in obesity via epigenetic changes. DNA methylation 
is the most studied epigenetic control mechanism that results in alteration of gene functions 
 [5] . In utero obesity-linked epigenetic modifications also result from potential impact of the 
environment and influence the phenotype of the infant and continue to effect the devel-
opment of obesity from infancy to adulthood  [4] . Lately obesity studies that focus on epigenetic 
factors are not only based on ‘obesogenic environment’ but on candidate gene approach 
(CGA) too. According to CGA, expression of insulin-like growth factor 2 ( IGF2 ) and proopi-
omelanocortin ( POMC ) genes correlate directly with growth, obesity, and body composition. 
 IGF2 along with  H19 are imprinted genes controlling the regulation of growth and body 
composition. IGF2 triggers a major signal transduction pathway via activation of the IGF1 
receptor, which mediates anabolic effects. Huang et al.  [6] found that through increased DNA 
methylation of the  IGF2/H19 region and therefore decreased expression of IGF2 leads to 
more subcutaneous fat mass in young adults.  POMC gene, which encodes an anorexogenic 
neuropeptide, plays a central role in body-weight regulation within the hypothalamus through 
regulation satiety and energy expenditure. According to  Marco et al. [8] in obesity the hypo-
thalamic signal transduction pathway might be impaired, since high fat diet treated rats with 
obesity showed hyper methylated  POMC promoter area. Kuehnen et al.  [7] and Marco et al. 
 [8] found that hypermethylation of the intron 2 and exon 3 boundary region of  POMC gene is 
associated with childhood obesity.
 The relationship between obesity and lower vitamin D levels has not been cleared yet. 
Vitamin D insufficiency and deficiency has become an issue worldwide. 25-hydroxy vitamin 
D (25OHD) is the dominant circulating form of vitamin D and tends to be a useful indicator of 
the actual vitamin D status  [9] . The activation and metabolism of 25OHD is a complex process, 
which also includes the cytochrome P450 enzymes in the kidney and liver, e.g. the activating 
enzyme 1-alfa-hydroxylase (CYP27B1) in the kidney. The activity and the expression of the 
genes encoding these enzymes are also modulated by epigenetic pathways such as DNA meth-
ylation  [10] . Vitamin D through its nuclear receptor (VDR) regulates epigenetic pathways and 
transcription of a number of genes involved in regulating metabolism and cell proliferation 
 [11, 12] . According to recent studies in adults, low levels of circulating 25OHD are associated 
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with increased fat mass, BMI, mortality, type 2 diabetes, cardiovascular diseases, and also 
dyslipidemia  [13–18] . The expression of vitamin D metabolism-related genes and vitamin D 
receptor genes has been investigated in several studies focusing on cancer but rarely in 
patients with metabolic problems, especially in children suffering from obesity  [19] . 
 Therefore, the aim of our study was to investigate whether there is a correlation between 
the rate of obesity ( BMI and BMI standard deviation score (SDS)) and the methylation status 
of genes related to vitamin D metabolism ( CYP27B1, VDR ) and metabolic status ( IGF2, POMC ) 
in Hungarian children with obesity.
 Material and Methods 
 Subjects 
 A total of 82 (40 boys and 42 girls) children were included in the study with age-and sex-specific BMIs 
above the 95th percentile, who were otherwise healthy and aged 3–18 years. Our probands were examined 
and followed up at the 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. 
 Anthropometric Data  
 Anthropometric data (height, weight, waist circumference, birth height, and birth length), metabolic 
parameters (lipid profile, fasting blood sugar, insulin, data of oral glucose tolerance test, and thyroid stimu-
lating hormone), vitamin D, serum calcium and parathormone levels as well as pubertal status were recorded, 
and a 24-hour blood pressure monitoring was carried out. BMI SDS was calculated in each case in order to 
estimate the relative degree of overweight. Patients’ history was taken focusing on mother’s weight gain 
during pregnancy, perinatal issues, development, eating habits, and lifestyle. We collected peripheral blood 
samples for DNA analysis from each patient. 
 The study was approved by the Semmelweis University Regional and Institutional Committee of Science 
and Research Ethics, and a written informed consent was provided in each case.
 DNA Isolation 
 Genomic DNAs were extracted from peripheral whole blood using QIAamp DNA Blood Mini KIT (250) 
(Qiagen Inc., Valencia, CA, USA) according to the manufacturers’ instructions.
 Quantitative Analysis of the Isolated DNA Samples 
 Concentrations of isolated nucleic acid samples were measured with NanoDrop 1000 spectropho-
tometer (Thermo Fisher Scientific Inc., Waltham, MA, USA).
 Bisulfite Conversion 
 Bisulfite conversion was performed using EZ DNA Methylation TM Kit (Zymo Research, Irvine, CA, USA) 
according to the manufacturer’s instructions. Based on NanoDrop spectrophotometer measurements, 
quantity of input DNA isolated from peripheral blood was 1 μg. Bisulfite-converted DNA (bcDNA) samples 
were eluted in 10 μl according to protocol. Concentrations of bcDNA samples were estimated by NanoDrop 
spectrophotometer using ‘ssDNA’ measurements. 
 Bisulfite-Specific PCR 
 In silico CpG island prediction of  CYP27B1, VDR, IGF2 and  POMC genes was performed by CpG Plot 
EMBOSS Application ( www.ebi.ac.uk/Tools/emboss/cpgplot/index.html ). For island prediction gene’s start 
codon ± 5–10 kb region was used. In order to select best target regions ENCODE DNA methylation data was 
analyzed by the UCSC Genome Browser ( https://genome.ucsc.edu ;  fig. 1 ). Bisulfite-specific PCR (BS-PCR) 
reactions were performed using primers designed with PyroMark Assay Design software (SW 2.0; Qiagen 
Inc.) to be specific for CpG regions in order to amplify the methylated sequence of the bcDNA samples. PCR 
primers in the opposite direction of sequencing primers were biotin-labelled ( table 1 ). Primer specificities 
were tested in silico by BiSearch software ( http://bisearch.enzim.hu ). Primers’ target regions were designed 
to cover all methylation sites that play role in gene regulation. In case of  IGF2 , after in silico testing primers 
targeting CpG sites in promoter region did not turn out to be specific. To avoid bias in analysis, specific 
primers targeting other CpG regions of  IGF2  were used. BS-PCR reactions were performed using AmpliTaq 
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Gold 360 Master Mix (Life Technologies, Carlsbad, CA, USA), LightCycler ® 480 ResoLight Dye (Roche Applied 
Science, Basel, Switzerland), primers at 0.2 μmol/l final concentrations, and bcDNA samples (20–40 ng 
bcDNA/reaction) in 15 μl final volume. The final concentration of MgCl 2 was 2.5 mmol/l except for the  VDR 
and  POMC , where it was 1.5 mmol/l. Real-time PCR amplification was carried out with the following thermo-
cycling conditions on the LightCycler 480 system: 95 ° C for 10 min, 95 ° C for 30 s, 60 ° C with 0.4 ° C decrease/
cycle for 30 s, 72 ° C for 30 s for 10 touchdown cycles, followed by amplification at 95 ° C for 30 s, 56 ° C for 30 
s, and 72 °  C for 30 s in 50 cycles. Following completion of the PCR thermal cycling, high resolution melting 
(HRM) analysis began with denaturation at 95 °  C for 1 min, cool down to 40 °  C, and hold for 1 min, then 
continuous warm up to 95 °  C with 20 acquisition/°  C rate during melting curve fluorescence acquisition. Cp 
values and normalized melting curves were retrieved after data preprocessing using the LightCycler 480 
software release 1.5.0 (Roche Applied Science). MS-HRM curve data were retrieved with the LightCycler ® 
Gene Scanning software (Roche Applied Science). 
 In order to calibrate our MS-HRM assays, artificially methylated DNA samples were mixed with non-
methylated standard samples after bisulfite conversion resulting in different DNA methylation ratios (0%, 
10%, 25%, 50%, 75%, 100%) and analyzed by MS-HRM. The average methylation level of all blood samples 
was estimated by two experts independently by visually comparing melting peak curves with those of 
standard samples. In the course of data processing the four parallel methylation values were verified, outliner 
values were excluded.
 Fig. 1. Genes’ loci and locations of bi-sulfite sequenced target regions. Investigated genes (labeled with light-
er blue). CpG islands (location labeled with dark green) and bi-sulfite sequenced target regions (labeled with 
dark blue) presented with UCSC Genome Browser.  (https://genome.ucsc.edu ).  A  CYP27B1   B  VDR  C  IGF2  D 
 POMC.  chr = Chromosome; Assay = bisulfite sequenced target region;  CYP27B1 = 1-alfa-hydroxylase gene; 
 VDR = vitamin D receptor gene,  IGF2 = insulin-like growth factor gene;  D = proopiomelanocortine gene.  
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 PyroMark Q24 Sequencing 
 Providing single-base resolution information about the methylation state of a CpG island, we used direct 
sequencing. After bisulfite treatment and BS-PCR, all cytosines are converted to thymines except for those 
originally methylated. Qiagen PyroMark System (Qiagen Inc.) pyrosequencing technology was applied to 
analyze DNA methylation of BS-PCR. The read length that can be analyzed with the then available PyroMark 
chemistry was limited to 100 bp. Pyrosequencing was performed on a PyroMark Q24 instrument (Qiagen 
Inc.) using PyroMark Gold Q24 Reagents (Qiagen Inc.) according to the manufacturer’s recommendations. 
Purification and subsequent processing of the biotinylated single-stranded DNA were performed in a run by 
applying (Qiagen Inc.) specific sequencing primers designed by PyroMark Assay Design software, SW 2.0 
(Qiagen Inc.) in order to cover CpG sites in the amplicons. Sequencing results were analyzed using the 
PyroMark Q24 software v2.0.6 (Qiagen Inc.). To define DNA methylation status the average methylation 
percentage of a gene region was estimated by pyrosequencing.
 Statistical Analysis 
 We used paired Student’s t test, Pearson correlation analysis, and linear regression models to inves-
tigate the connection between the DNA methylation status, vitamin D levels and the metabolic parameters. 
Statistical analysis was performed by GraphPad Prism 6 (2015 GraphPad Software, Inc., La Jolla, CA, USA) 
and SPSS Version 20.0 ( 2011 IMB Corporation, Armonk, NY, USA).
 Results 
 While analyzing data one proband showed extreme weight (159.2 kg) and BMI SDS 
(16.38) values. To avoid data distortion, the patient was considered as outlier and got excluded 
from further examination.
 At the time of inclusion, 33 of 42 girls and 27 of 40 boys were in puberty, the average age 
of the two genders was close (girls: 12.52 ± 3.10 years, boys: 12.94 ± 2.69 years). After 
comparing anthropometric and metabolic status of girls and boys, we found that according to 
BMI SDS girls tend to be more obese than boys (4.51 ± 0.29 vs. 3.96 ± 0.24; p = 0.1571), the 
mother’s weight gain during pregnancy was more pronounced in boys’ than in girls’ (13.67 ± 
2.51 vs. 11.94 ± 1.47; p = 0.5488), and glutamate pyruvate transaminase (GPT) (28.10 ± 3.813 
vs.18.23 ± 1.335, p = 0.0228) and alkaline phosphatase (ALP) (230.3 ± 16.41 vs. 184.2 ± 
15.589; p = 0.0452) levels were significantly lower in girls than in boys (supplementary 
table 1, available at  http://content.karger.com/ProdukteDB/produkte.asp?doi=477462 ).
 Table 1.  Target genes, assays and forward, biotinylated reverse primers for bisulfite-specific PCR and sequencing primers for 
pyrosequencing
Targ et gene 
and assay
Forward primer Reverse primer (biotinylated) Sequencing primer
CYP27B1
Assay 1
GGTTTTTGGGGGTAGAGAAGAT CTCCCTATTCCCAAACCCAATCAA GGGGGTAGAGAAGATTTA
CYP27B1
Assay 2
AGAGGGGTTTGGGATGTT AACCCTCAAATACCCCTCCAAAATATTCCAT GGGATGTTTGTTAAGTT
VDR
Assay 2
GGATTAGGGATTAGGGAAGTTGAGATTTA TACTACTACAAAACCCCAAAAAACTCAACCTAA AGATTTAGTTTTTTTGGGTGA
VDR
Assay 3
ATTTTAATTTGTGGGATTAGGTTGAGT TAATCCAAAATACAACCCCCCACCCTTCCTAC TGGAGTTTTGTAGTAGTAATAGG
IGF2
Assay1
GGGATTGGGTTAGGAGAAGT CCCCCCCAAAAATAACCAACAAT GGGTTAGGAGAAGTTTTA
POMC 
Assay 7
GTTGGAAAGGGGTTGGAATTAGTA ACACCCACAAAACCACTCCTAACTTCTAC TTTAGGAAGAATTTAATTATGGAT
 CYP27B1 = 1-alfa-hydroxylase gene, VDR =  vitamin D receptor gene; IGF2 = insulin-like growth factor gene; POMC = proopiomelanocortin gene.
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 27 of 82 children with obesity had either hypertension (according to 24-hour blood 
pressure monitoring), carbohydrate metabolism disorder (according to oral glucose tolerance 
test – impaired glucose tolerance), and/or dyslipidemia (elevated cholesterol level). One 
patient had all three of the above mentioned comorbidities mentioned above and also 
presented elevated uric acid level. According to our results, hypertension and dyslipidemia 
individually was present in 18.29–18.29% and carbohydrate metabolism disorder was 
present in 13.41% of the cases. Nine of the 55 patients without hypertension, impaired 
glucose tolerance, and dyslipidemia presented isolated hyperuricemia (data not shown). 46 
patients did not present any signs of comorbidities (supplementary fig. 1, available at  http://
content.karger.com/ProdukteDB/produkte.asp?doi=477462 ).
 There was no significant correlation between the 25-OH vitamin D levels and metabolic 
parameters and DNA methylation status. There was a tendency of positive correlation of  VDR 
methylation status and vitamin D levels (supplementary table 2, available at  http://content.
karger.com/ProdukteDB/produkte.asp?doi=477462 ).
 Significant positive correlations between BMI SDS and waist circumference (r = 0.5655, 
p < 0.0001), fasting insulin level (r = 0.3539, p = 0.0013), Homeostasis Model Assessment 
(HOMA) index (r = 0.2757, p = 0.0122) , uric acid levels (r = 0.2333, p = 0.0373) as well as 
 CYP27B1 methylation status (r = 0.2371, p = 0.0342) were found.  IGF2 methylation status and 
BMI SDS showed significant negative correlation (r = –0.305, p = 0.0059). While performing 
statistical analysis, excluding these potential outliers did not modify the significance of the 
found correlations (supplementary table 3, available at  http://content.karger.com/
ProdukteDB/produkte.asp?doi=477462 ) ( fig. 2 .)
 Fig. 2. Significant correlations of BMI SDS and anthropometric, metabolic parameters and methylation sta-
tus. Significant positive correlations between BMI SDS and waist circumference ( A ) (r = 0.5655, p < 0.0001), 
fasting insulin level ( B ) (r = 0.3539, p = 0.0013), HOMA index ( C ) (r = 0.2757,p = 0.0122) , uric acid levels ( D ) 
(r = 0.2333, p = 0.0373) , CYP27B1 methylation status ( E ) (r = 0.2371, p = 0.0342). Assessment IGF2 meth-
ylation status and BMI SDS ( F ) showed significant negative correlation (r = –0.305, p = 0.0059). BMI SDS = 
BMI standard deviation score, HOMA: Homeostasis model; CYP27B1 =  1-alfa-hydroxylase gene;  IGF2 =  insu-
lin-like growth factor gene.  
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 To further analyze the possible effects of DNA methylation status of  CYP27B1 and IGF2 
genes and 25OH vitamin D on the BMI SDS, linear regression was performed. Because it is 
already known that IGF2 is associated with growth and body composition, vitamin D can be 
associated with higher BMI, and CYP27B1 converts 25OH vitamin D to the active form 
1,25(OH)2 vitamin D, we included these variables into our analyses. We entered variables 
stepwise with the linear regression function of SPSS. If a variable did not improve model fit, 
it was excluded from the model (backward elimination). 
 Model 1 included  CYP27B1 , IGF2 methylation status, and vitamin D level as variables. 
 CYP27B1 and  IGF2 methylation status were significantly associated with BMI SDS while 
vitamin D level did not show significant association (supplementary table 4, available at 
 http://content.karger.com/ProdukteDB/produkte.asp?doi=477462 ). Vitamin D did not 
improve model fit; therefore, it was excluded from the final model (adjusted R 2 = 0.96 vs. 
0.98). Model 2 accounted for 9.8% of the variance and was statistically significant (F(2,78) = 
5.246 p = 0.007) (supplementary table 5, available at  http://content.karger.com/ProdukteDB/
produkte.asp?doi=477462 ).
 Discussion 
 The prevalence of obesity among children has been rising enormously over the past 
decades  [20] . Children suffering from obesity tend to have higher risk for several obesity-
related problems such as high blood pressure, dyslipidemia, and type 2 diabetes mellitus 
during adolescence and later on during adulthood  [21, 22] . They are also more likely to 
remain obese as adults  [23, 24] . Several studies have suggested that imprinting and methyl-
ation can play role in weight control and obesity  [25–28] . According to our results, there were 
significant positive correlations between BMI SDS and waist circumference, fasting insulin or 
glucose levels, HOMA index, uric acid level as well as higher blood pressure. 18.29% of our 
patients had either hypertension or impaired carbohydrate metabolism, while dyslipidemia 
was present in 13.41% and hyperuricemia in 10.97% of the cases. Altogether, 43.9% of these 
children with obesity already presented at least one of the main metabolic and cardiovascular 
risks of obesity. Our findings support the hypothesis that with early onset obesity the meta-
bolic consequences of this condition start getting in action very early on in life  [1] .
 Recent studies observed that increased BMI is associated with low circulating 25OH 
vitamin D levels, but no evidence was proven for elevated 25OH vitamin D lowering either 
weight or BMI  [29] . Increased VDR function is associated with increased body fat and unfa-
vorable lipid profile in mice  [30] . Interestingly, our results did not show any significant corre-
lations between 25OH vitamin D and BMI SDS, metabolic status-describing parameters, blood 
pressure increase or VDR methylation status. Therefore, we could not confirm the association 
between lower vitamin D levels and unfavorable metabolic profiles  [31] . However, the 
increased methylation of the gene of the 25OH vitamin D activating CYP27B1 enzyme was 
associated with higher BMI SDS. Lower CYP27B1 expression in subcutaneous adipose tissue 
in adults with obesity was found by Wamberg et al.  [10] . These findings indicate that 1,25(OH)2 
vitamin D, the active form of vitamin D, might be reduced in individuals with obesity – in 
adults and in children as well.
 IGF2 is an important regulator of growth, obesity, and body composition. In young adults, 
 IGF2 hypermethylation was associated with greater subcutaneous adiposity, but not with 
BMI, weight, height, waist circumference or visceral adiposity  [6] . According to Chen et al. 
 [32] , in women suffering from obesity  IGF2 methylation level was lowest in subcutaneous 
adipose tissue when compared with that in visceral adipose tissue or muscle. While studying 
Mexican-American lean and obese children Hernandez-Valerio et al.  [33] found that children 
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with lower  IGF2/H19 methylation had higher birth weights than did children with higher 
methylation. Heijmans et al.  [34] stated a negative association between  H19 methylation and 
body size. Supporting this, our data also show significant negative correlation between  IGF2 
methylation and increased BMI SDS. Therefore, we suggest that the lower IGF2 and  H19 meth-
ylation status tend to have an impact not only on birth weight but later in childhood on the 
level of obesity described by BMI SDS.
 According to our results, the methylation status of the  POMC  gene, which encodes an 
anorexogenic neuropeptide and plays key role in body weight regulation within the hypo-
thalamus, did not show any correlations with BMI SDS. This might be due to the fact that CpG 
islands within one gene can be differently methylated and the primer used in our study 
targeted the gene’s exon 1 region, while Kuehnen et al.  [7] found association with childhood 
obesity and the hypermethylation of the intron 2 and exon 3 boundary region of  POMC gene.
 To analyze the possible effects of DNA methylation status of  CYP27B1 and  IGF2 genes and 
25OH vitamin D on BMI SDS we preformed linear regression.  CYP27B1 and  IGF2 methylation 
status were significantly associated with BMI SDS, while vitamin D level did not show any 
significant association, which suggests that hypomethylation of  IGF2 and the hypermethyl-
ation of  CYP27B1 might positively influence the rate of BMI observed in children with obesity. 
This can be explained by the fact that hypomethylation of the  IGF2 gene might lead to increased 
expression of IGF2, which is responsible for growth and somatic development, and is asso-
ciated with increased visceral fat mass  [6] . Higher DNA methylation of the  CYP27B1 gene can 
lead to decreased enzyme activity and lower levels of active 1,25(OH)2 vitamin D. According 
to experimental studies, 1,25(OH)2 vitamin D has an active role in adipose tissue by modu-
lating inflammation, adipogenesis, and adipocyte secretion  [29] . We speculate that potential 
lower active vitamin D and increased IGF2 levels alter adipose tissue function and metab-
olism towards the direction of increasing BMI SDS.
 To our knowledge, this is first study examining the methylation status of genes related to 
vitamin D metabolism related ( CYP27B1  and  VDR ) and to metabolic status ( IGF2  and  POMC ) 
in children with obesity. Although our research has reached its aims, there were some 
unavoidable limitations. First, because genomic DNA was extracted from peripheral whole 
blood includig many different cell types, we cannot provide correction for cell composition. 
Since DNA methylation is tissue-specific, adipocytes might show different methylation 
patterns than blood cells. Second, considering the epigenetic contribution to the pathogenesis 
of obesity, besides DNA methylation, other epigenetic pathways could influence the level of 
obesity. Therefore, further epigenetic researches are needed on this topic. Third, due to our 
relative small sample size and the seasonal and ethnic variation in vitamin D levels, confor-
mation of our results by further investigations on larger populations are needed. 
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